Abiopharma

🔍 Bicket John (Executive)

Company: Samsara Inc. (IOT)

Report Date: 2026-04-14

Detailed Transactions and Holdings:

• Sold 115,895 shares of Class A Common Stock at $26.5772 per share (Direct)
  Date: 2026-04-14 | Code: S | equity_swap_involved: 0 | shares_owned_after: 869,933.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Sold 938 shares of Class A Common Stock at $27.3195 per share (Direct)
  Date: 2026-04-14 | Code: S | equity_swap_involved: 0 | shares_owned_after: 868,995.00 | transaction_form_type: 4 | Footnotes: F1, F4, F3
• Sold 10,600 shares of Class A Common Stock at $26.8002 per share (Direct)
  Date: 2026-04-14 | Code: S | equity_swap_involved: 0 | shares_owned_after: 36,400.00 | transaction_form_type: 4 | Footnotes: F5, F6, F7
• Sold 39,434 shares of Class A Common Stock at $26.5764 per share (Direct)
  Date: 2026-04-14 | Code: S | equity_swap_involved: 0 | shares_owned_after: 164,066.00 | transaction_form_type: 4 | Footnotes: F5, F8, F9
• Sold 343 shares of Class A Common Stock at $27.3054 per share (Direct)
  Date: 2026-04-14 | Code: S | equity_swap_involved: 0 | shares_owned_after: 163,723.00 | transaction_form_type: 4 | Footnotes: F5, F10, F9
• Sold 25,716 shares of Class A Common Stock at $27.6564 per share (Direct)
  Date: 2026-04-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 843,279.00 | transaction_form_type: 4 | Footnotes: F1, F11, F3
• Sold 65,451 shares of Class A Common Stock at $28.1437 per share (Direct)
  Date: 2026-04-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 777,828.00 | transaction_form_type: 4 | Footnotes: F1, F12, F3
• Sold 3,296 shares of Class A Common Stock at $27.3831 per share (Direct)
  Date: 2026-04-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 160,427.00 | transaction_form_type: 4 | Footnotes: F5, F13, F9
• Sold 2,227 shares of Class A Common Stock at $27.9655 per share (Direct)
  Date: 2026-04-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 158,200.00 | transaction_form_type: 4 | Footnotes: F5, F14, F9
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-04-14 | Code: H | shares_owned_after: 200,161.00 | Footnotes: F15

Footnotes:

• F1: The sales were effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025 by John C. Bicket, Trustee of the John C. Bicket Revocable Trust u/a/d 2/15/2013, over which the Reporting Person has voting or investment power (the "Bicket Revocable Trust").
• F2: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $26.27 to $27.23, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
• F3: Consists of shares held by the Bicket Revocable Trust.
• F4: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $27.275 to $27.38, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
• F5: The sales were effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025 by Jordan Park Trust Company LLC, Trustee, by Courtney J. Maloney as Trust Officer.
• F6: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $26.42 to $27.36, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
• F7: Consists of shares held by Jordan Park Trust Company, LLC, Trustee of The Bicket-Dobson Trust I u/a/d 11/10/2021, over which the Reporting Person has voting or investment power.
• F8: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $26.28 to $27.22, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
• F9: Consists of shares held by Jordan Park Trust Company, LLC, Trustee of The Bicket-Dobson Trust II u/a/d 10/8/2021, over which the Reporting Person has voting or investment power.
• F10: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $27.30 to $27.32, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
• F11: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $26.865 to $27.86, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
• F12: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $27.865 to $28.555, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
• F13: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $26.82 to $27.81, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
• F14: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $27.83 to $28.15, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
• F15: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
• REMARKS: Executive Vice President, Chief Technology Officer